The ethical practices for human biobanks in China are intended to safeguard the interests of all the participants, to standardize the construction, management, and resource sharing of human biobanks, to promote the development of medical research, and to improve public health and well-being. The practices contain several chapters: General Principles; Ethics Review; Informed Consent; Privacy Protection; Benefits of Sharing; and Conflict of Interest.
Get full access to this article
View all access options for this article.
References
1.
Ministry of Science and Technology of the People's Republic of China. Regulations on the Administration of Human Genetic Resources of the People's Republic of China. Available from www.gov.cn/zhengce/content/2019-06/10/content_5398829.htm (accessed March30, 2020).
2.
Health and Committee of the People's Republic of China. Regulations for Ethics Review of Biomedical Research Involving Human. Available from www.gov.cn/gongbao/content/2017/content_5227817.htm (accessed March30, 2020).
3.
Council for International Organizations of Medical Sciences (CIOMS) in Collaboration with the World Health Organization (WHO). International Ethical Guidelines for Health-Related Research Involving Humans. Geneva: WHO Press; 2016.
National Bioethics Advisory Commission Research Involving. Human Biological Material: Ethical Issues and Policy Guidance. Rockville: US Government Printing Office; 1999. Available from https://bioethicsarchive.georgetown.edu/nbac/hbm.pdf (accessed March30, 2020).
International Society for Biological and Environmental Repositories. ISBER Best Practices for Repositories; 2018. Available from www.isber.org/page/BPR (accessed March30, 2020).
9.
ZaiX, QiuR. Introduction to Bioethics. Beijing, China: Tsinghua University Press; 2017.
